tirzepatide from lilly Eli launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can FDA says the tirzepatide weight-loss

This decision helps to preserve coverage for other lifesaving procedures and treatment options for the 5.2 million people who count on their Blue Cross health coverage

There was a striking side effect: significant weight loss

Male mice exposed to CMS for 2 weeks showed increased pathogenic bacteria including Acinetobacter, Proteus , and Enterococcus (Tyagi et al., 2025)

In addition to regular check-ups, patients must consume sufficient amounts of carbohydrates through their diet

Because plasma is used to create life-saving treatments for individuals with rare diseases and immune deficiencies, the safety of the donor and the recipient is paramount

Sources Nguyen, T